Endogenous glutamine production in critically ill patients: The effect of exogenous glutamine supplementation

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Mori, Maiko ^a   Rooyackers, Olav ^a   Smedberg, Marie ^a   Tjäder, Inga ^a   Norberg, Åke ^a   Wernerman, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; DIPEPTIDE; GLUTAMINE; LEVO ALANYL LEVO GLUTAMINE; PHENYLALANINE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; SUPPLEMENTATION; TREATMENT RESPONSE; VENTILATED PATIENT; ADULT; AGED; ARTIFICIAL VENTILATION; BLOOD; CRITICAL ILLNESS; DIET SUPPLEMENTATION; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; FEMALE; GLUTAMINE; HUMANS; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PILOT PROJECTS; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 84899946400     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13829     Document Type: Article

References (22)

1. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90. 10.1007/s001340000703, 11280678.
2. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597. 10.1042/CS20110520, 3294430, 22248298.
3. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2013, 32:213-223. 10.1016/j.clnu.2012.11.003, 23196117.
4. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28:387-400. 10.1016/j.clnu.2009.04.024, 19505748.
5. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497. 10.1056/NEJMoa1212722, 23594003.
6. Jackson NC, Carroll PV, Russell-Jones DL, Sonksen PH, Treacher DF, Umpleby AM. The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am J Physiol 1999, 276:E163-E170.
7. Darmaun D, Matthews DE, Bier DM. Glutamine and glutamate kinetics in humans. Am J Physiol 1986, 251:E117-E126.
8. Matthews DE, Campbell RG. The effect of dietary protein intake on glutamine and glutamate nitrogen metabolism in humans. Am J Clin Nutr 1992, 55:963-970.
9. Kreider ME, Stumvoll M, Meyer C, Overkamp D, Welle S, Gerich J. Steady-state and non-steady-state measurements of plasma glutamine turnover in humans. Am J Physiol 1997, 272:E621-E627.
10. Berg A, Bellander BM, Wanecek M, Norberg A, Ungerstedt U, Rooyackers O, Wernerman J. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients. Clin Nutr 2008, 27:816-821. 10.1016/j.clnu.2008.06.006, 18649974.
11. Berg A, Norberg A, Martling CR, Gamrin L, Rooyackers O, Wernerman J. Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Med 2007, 33:660-666. 10.1007/s00134-007-0547-9, 17318498.
12. Mori M, Smedberg M, Klaude M, Tjäder I, Norberg T, Rooyackers O, Wernerman J. A tracer bolus method for investigating glutamine kinetics in humans. PloS ONE 2014, (in press). Epub 2014 May 8.
13. van Acker BA, Hulsewe KW, Wagenmakers AJ, Soeters PB, von Meyenfeldt MF. Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. J Nutr 2000, 130:1566-1571.
14. van Acker BA, Hulsewe KW, Wagenmakers AJ, von Meyenfeldt MF, Soeters PB. Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. Am J Clin Nutr 2000, 72:790-795.
15. Jackson NC, Carroll PV, Russell-Jones DL, Sonksen PH, Treacher DF, Umpleby AM. Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients. Am J Physiol Endocrinol Metab 2000, 278:E226-E233.
16. Berg A, Rooyackers O, Norberg A, Wernerman J. Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids 2005, 29:221-228. 10.1007/s00726-005-0230-9, 16049639.
17. Darmaun D, Matthews DE, Bier DM. Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am J Physiol 1988, 255:E366-E373.
18. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002, 30:2032-2037. 10.1097/00003246-200209000-00013, 12352037.
19. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
20. Tjader I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Wernerman J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 2004, 30:266-275. 10.1007/s00134-003-2048-9, 14722645.
21. Biolo G, Fleming RY, Maggi SP, Nguyen TT, Herndon DN, Wolfe RR. Inhibition of muscle glutamine formation in hypercatabolic patients. Clin Sci (Lond) 2000, 99:189-194. 10.1042/CS19990254, 11787470.
22. Vesali RF, Klaude M, Rooyackers OE, TJäder I, Barle H, Wernerman J. Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients. Clin Nutr 2002, 21:505-514. 10.1054/clnu.2002.0583, 12468371.